On ECHEMI
Home > Drugs > Iodine-induced hyperthyroidism
Iodine-induced hyperthyroidism
Iodine-induced hyperthyroidism (IIH) refers to hyperthyroidism related to increased iodine intake, also known as iodine-induced hyperthyroidism or iodine-induced thyrotoxicosis (IIT). From the perspective of iodine intake, there are three situations in which iodine-induced hyperthyroidism occurs: the first is caused by one or more large doses of iodine intake, such as taking iodine-containing drugs such as amiodarone or using contrast agents. It can occur in people with normal iodine nutrition and is more likely to occur in people with nodular goiter; the second is the intake of higher doses of iodine, which often occurs in high-iodine areas and occurs due to long-term intake of higher doses of iodine; the third is the intake of normal doses of iodine (which can be iodine intake within the physiological range), which is seen in patients with goiter in iodine-deficient areas (including marginal iodine-deficient areas) after taking iodized salt; patients with goiter in non-iodine-deficient areas after taking iodine; and patients with controlled hyperthyroidism who relapse after taking iodine.
  • Site of disease:

    thyroid
  • Infectious :

    Not contagious
  • Frequent population:

    People in high iodine areas
  • Related symptoms:

    Hypermetabolism syndrome iodine hyperthyroidism vascular murmur tachycardia goiter
  • Concurrent disease:

Related Drugs
Propylthiouracil Tablets
Indication: It is used for various types of hyperthyroidism, especially for: 1. Patients with mild disease and mild to moderate thyroid enlargement; 2. Adolescents, children and elderly patients; 3. Patients with recurrence after thyroid surgery who are not suitable for radioactive 131I treatment; 4. Pre-operative preparation; 5. As an adjuvant treatment for 131I radiotherapy.
Manufacturer:

Jinghua Pharmaceutical Group Co., Ltd.

Carbimazole tablets
Indication: It is suitable for various types of hyperthyroidism, especially for: 1. Patients with mild disease and mild to moderate thyroid enlargement; 2. Adolescents, children and elderly patients; 3. Patients with recurrence after thyroid surgery who are not suitable for treatment with radioactive 131I; 4. Preparation before surgery; 5. As an adjuvant treatment for 131I radiotherapy.
Manufacturer:

Jinyao Pharmaceutical Co., Ltd.

Propylthiouracil Enteric-coated Tablets
Indication: It is used for various types of hyperthyroidism, including toxic diffuse goiter (Graves' disease). In Graves' disease, it is especially suitable for: 1. Patients with mild to moderate thyroid enlargement; 2. Children, adolescents and elderly patients; 3. Patients with recurrence after thyroid surgery but not suitable for radioactive 131I treatment; 4. Preparation before surgery; 5. As an adjuvant treatment for 131I radiotherapy.
Manufacturer:

Jilin Aodong Yanbian Pharmaceutical Co., Ltd.

Propylthiouracil Enteric-coated Capsules
Indication: It is used for various types of hyperthyroidism, including toxic diffuse goiter (Graves' disease). In Graves' disease, it is especially suitable for: 1. Patients with mild to moderate thyroid enlargement; 2. Children, adolescents and elderly patients; 3. Patients with recurrence after thyroid surgery but not suitable for radioactive 131I treatment; 4. Preparation before surgery; 5. As an adjuvant treatment for 131I radiotherapy.
Manufacturer:

Jilin Aodong Yanbian Pharmaceutical Co., Ltd.

Atenolol Tablets
Indication: It is mainly used to treat hypertension, angina pectoris, and myocardial infarction, and can also be used for arrhythmia, hyperthyroidism, and pheochromocytoma.
Manufacturer:

Beijing Wanhui Double-Crane Pharmaceutical Company Limited

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.